Search for: "Lisa Nicholson "
Results 1 - 20
of 82
Sort by Relevance
|
Sort by Date
23 Jan 2024, 11:32 am
Other pre-ChatGPT work I found helpful: Carys Craig (copyright and AI authorship) Daryl Lim (AI and innovation policy), Arti Rai & Nicholson Price (medicine drug development machine learning). [read post]
29 Dec 2022, 9:05 pm
In lieu of our regular Friday feature—the Week in Review—The Regulatory Review is recapping some of the top regulatory news from the past year, including major U.S. [read post]
22 Jul 2022, 2:00 am
Lisa Larrimore Ouellette (Stanford University), W. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Mar 2022, 6:43 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
21 Jan 2022, 8:35 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
6 Dec 2021, 6:24 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
5 Nov 2021, 8:20 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
12 Oct 2021, 2:00 am
Nicholson Price II (University of Michigan) Jacob S. [read post]
27 Sep 2021, 7:26 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
4 Sep 2021, 7:11 am
Mathes, and Kenisha Nicholson. [read post]
27 Aug 2021, 12:18 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
17 Aug 2021, 9:28 am
Lisa L. [read post]
17 Aug 2021, 9:28 am
Lisa L. [read post]
30 Jul 2021, 5:03 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
30 Jun 2021, 10:31 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
3 May 2021, 8:36 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWe have written before about the challenges of making decisions under scientific uncertainty and the simultaneous importance and difficulty of developing high-quality clinical evidence under pandemic circumstances. [read post]
9 Apr 2021, 8:03 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
25 Mar 2021, 1:24 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
